Citation: M. Yao et al., Quantitation of itraconazole in rat heparinized plasma by liquid chromatography-mass spectrometry, J CHROMAT B, 752(1), 2001, pp. 9-16
Authors:
Krishna, R
Yao, M
Kaczor, D
Vachharajani, N
Srinivas, NR
Citation: R. Krishna et al., In vitro protein binding studies with BMS-204352: Lack of protein binding displacement interaction in human serum, BIOPHARM DR, 22(1), 2001, pp. 41-44
Citation: Nr. Srinivas et al., Enantiomeric drug development: Issues, considerations, and regulatory requirements, J PHARM SCI, 90(9), 2001, pp. 1205-1215
Citation: M. Yao et Nr. Srinivas, Simultaneous quantitation of d7-nefazodone, nefazodone, d7-hydroxynefazodone, hydroxynefazodone, m-chlorophenylpiperazine and triazole-dione in humanplasma by liquid chromatographic-mass spectrometry, BIOMED CHRO, 14(2), 2000, pp. 106-112
Citation: Nr. Srinivas et Wc. Shyu, Single dose and multiple dose pharmacokinetics of 2 '-fluoro-2 ',3'-dideoxyadenosine and 2 '-fluoro-2 ',3 '-dideoxyinosine, anti-HIV agents, in rats, EUR J DRUG, 24(4), 1999, pp. 329-334
Authors:
Chang, SY
Whigan, D
Shyu, WC
Srinivas, NR
Citation: Sy. Chang et al., Sensitive triple-quadrupole mass spectrometric assay for the determinationof BMS-181885, a 5-HT1 agonist, in human plasma following solid phase extraction, BIOMED CHRO, 13(6), 1999, pp. 425-430